Release Date: 15/03/16 08:23 Summary: December 2015 Half Year Results Presentation Price Sensitive: No Download Document 2.39MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%